Literature DB >> 30021362

Neuroprotective activity of tetramethylpyrazine against 3-nitropropionic acid induced Huntington's disease-like symptoms in rats.

Ravi Chandra Sekhara Reddy Danduga1, Subba Reddy Dondapati2, Phani Kumar Kola3, Lilly Grace3, Rahil Vandana Bisky Tadigiri3, Vijaya Kishore Kanakaraju4.   

Abstract

Huntington's disease (HD) is an autosomal neurodegenerative disease characterized by chorea, dystonia, motor ataxia, cognitive decline and psychiatric disorders with gradual loss of nerve cells and has no existing cure for the disease. In the present study, a mitochondrial toxin, 3-nitropropionic acid (3-NP) is used to induce HD like symptoms in rats. Tetramethylpyrazine is one of the active ingredients of Chuan Xiong which was reported to have neurotrophic and neuroprotective activities. The present study was designed to evaluate the role of TMP on 3-NP induced behavioral, biochemical, neurochemical, and histological alterations in the different regions of the brain. Animals were pretreated with normal saline/TMP for 7 days. From 8th day, the treatment groups were co-administered with 3-NP (10 mg/kg, i.p) and continued to the 21st day of the treatment protocol. At the end of the study, we found that the TMP improved all the behavioral performances of 3-NP induced neurotoxic rats, significantly. Further, oxidative stress parameters (lipid peroxidation, reduced glutathione, catalase, and superoxide dismutase), succinate dehydrogenase enzyme, and neurochemical (GABA and glutamate) estimations were done in the brain homogenate. In our study, the treatment with TMP ameliorated the 3-NP induced alterations, in the biochemical and neurochemical parameter in the brain homogenate, dose-dependently. The protective role of TMP further confirmed by measuring the lesion area with the 2,3,5-triphenyltetrazolium chloride staining of the brain slices and histopathological alteration in the hippocampus (CA1 and CA3) and striatal regions of the brain. Hence, the present findings suggest that the protective role of TMP against 3-NP induced behavioral, biochemical, neurochemical, and histological alterations in rats.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  3-nitropropionic acid; Histopathology; Huntington’s disease; Neurochemicals; Oxidative stress; Tetramethylpyrazine

Mesh:

Substances:

Year:  2018        PMID: 30021362     DOI: 10.1016/j.biopha.2018.06.079

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  8 in total

1.  Therapeutic potential of probiotics - Lactobacillus plantarum UBLP40 and Bacillus clausii UBBC07 on thioacetamide-induced acute hepatic encephalopathy in rats.

Authors:  Lalita Shahgond; Chirag Patel; Khushboo Thakur; Dipta Sarkar; Sanjeev Acharya; Priyanshi Patel
Journal:  Metab Brain Dis       Date:  2021-11-03       Impact factor: 3.584

Review 2.  Analgesic Alkaloids Derived From Traditional Chinese Medicine in Pain Management.

Authors:  Wei Jiang; Mingze Tang; Limin Yang; Xu Zhao; Jun Gao; Yue Jiao; Tao Li; Cai Tie; Tianle Gao; Yanxing Han; Jian-Dong Jiang
Journal:  Front Pharmacol       Date:  2022-05-10       Impact factor: 5.988

3.  Inhibition of Brain GTP Cyclohydrolase I Attenuates 3-Nitropropionic Acid-Induced Striatal Toxicity: Involvement of Mas Receptor/PI3k/Akt/CREB/ BDNF Axis.

Authors:  Aya M Mustafa; Mostafa A Rabie; Hala F Zaki; Aya M Shaheen
Journal:  Front Pharmacol       Date:  2021-12-22       Impact factor: 5.810

4.  Recombinant human erythropoietin and interferon-β-1b protect against 3-nitropropionic acid-induced neurotoxicity in rats: possible role of JAK/STAT signaling pathway.

Authors:  Rabab H Sayed; Amira H Ghazy; Mohamed F El Yammany
Journal:  Inflammopharmacology       Date:  2022-03-06       Impact factor: 4.473

5.  Protective effect of probiotics and ascorbic acid on bile duct ligation-induced chronic hepatic encephalopathy in rats.

Authors:  Chirag Patel; Lalita Shahgond; Sanjeev Acharya; Sai Hs Boddu; Ketan Ranch
Journal:  Res Pharm Sci       Date:  2022-07-14

6.  Ligustrazine eases lung cancer by regulating PTEN and Wnt/β-catenin pathway.

Authors:  Yuehua Dong; Yanjun Yang; Yulei Wei; Yongshan Gao; Weihua Jiang; Guigang Wang
Journal:  Transl Cancer Res       Date:  2020-03       Impact factor: 1.241

Review 7.  Expanding the Arsenal Against Huntington's Disease-Herbal Drugs and Their Nanoformulations.

Authors:  Sukriti Vishwas; Monica Gulati; Bhupinder Kapoor; Saurabh Gupta; Sachin Kumar Singh; Ankit Awasthi; Arzoo Khan; Aditya Goyal; Anil Bansal; Suman Baishnab; Thakur Gurjeet Singh; Sandeep Arora; Omji Porwal; Ankit Kumar; Vijay Kumar
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

Review 8.  The Roles of Tetramethylpyrazine During Neurodegenerative Disease.

Authors:  Zeyu Meng; Huize Chen; Shengxi Meng
Journal:  Neurotox Res       Date:  2021-08-05       Impact factor: 3.911

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.